Nonoperating Income (Expense) in USD of Sigyn Therapeutics, Inc. from 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Sigyn Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from 2015 to Q3 2025.
  • Sigyn Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was -$192K, a 50.6% increase year-over-year.
  • Sigyn Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was -$1.34M, a 8.58% decline year-over-year.
  • Sigyn Therapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was -$821K, a 51.4% increase from 2023.
  • Sigyn Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.69M, a 116% decline from 2022.
  • Sigyn Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$783K, a 21.5% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Sigyn Therapeutics, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$1.34M -$192K +$196K +50.6% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 -$1.54M -$982K -$722K -278% 01 Apr 2025 30 Jun 2025 10-Q 05 Sep 2025
Q1 2025 -$815K -$123K +$5.61K +4.38% 01 Jan 2025 31 Mar 2025 10-Q 20 May 2025
Q4 2024 -$821K -$44.8K +$414K +90.2% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025
Q3 2024 -$1.23M -$388K -$126K -47.8% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 -$1.11M -$260K -$110K -74.1% 01 Apr 2024 30 Jun 2024 10-Q 05 Sep 2025
Q1 2024 -$999K -$128K +$692K +84.4% 01 Jan 2024 31 Mar 2024 10-Q 20 May 2025
Q4 2023 -$1.69M -$459K -$71.5K -18.4% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 -$1.62M -$263K -$70.1K -36.3% 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024
Q2 2023 -$1.55M -$149K -$15.6K -11.7% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024
Q1 2023 -$1.53M -$820K -$751K -1091% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 -$783K -$387K +$249K +39.1% 01 Oct 2022 31 Dec 2022 10-K 20 Feb 2024
Q3 2022 -$1.03M -$193K -$100K -108% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$931K -$134K +$74.5K +35.8% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$1.01M -$68.8K -$9.22K -15.5% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$996K -$636K -$529K -492% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$468K -$92.5K +$472 +0.51% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$468K -$208K -$124K -146% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$345K -$59.6K -$1.38K -2.38% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022
Q4 2020 -$343K -$107K +$2.64M +96.1% 01 Oct 2020 31 Dec 2020 10-K 21 Mar 2022
Q3 2020 -$2.98M -$93K -$77.2K -487% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$2.91M -$84.5K -$69K -445% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 -$2.84M -$58.2K -$42.7K -276% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 -$2.8M -$2.75M -$1.78M -183% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2020
Q3 2019 -$1.02M -$15.9K +$71.4K +81.8% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 -$1.09M -$15.5K -$97K -119% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020
Q1 2019 -$991K -$15.5K +$309K +95.2% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 -$1.3M -$970K -$693K -250% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020
Q3 2018 -$607K -$87.2K +$830K +90.5% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$1.44M $81.5K +$434K 01 Apr 2018 30 Jun 2018 10-Q 05 Aug 2019
Q1 2018 -$1.87M -$324K -$54.3K -20.1% 01 Jan 2018 31 Mar 2018 10-Q 19 Apr 2019
Q4 2017 -$1.82M -$277K 01 Oct 2017 31 Dec 2017 10-K 01 Apr 2019
Q3 2017 -$917K -$814K -790% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$352K -$710K -198% 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018
Q1 2017 -$270K -$405K -299% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q3 2016 -$103K 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2016
Q2 2016 $358K 01 Apr 2016 30 Jun 2016 10-Q 04 Aug 2016
Q1 2016 $135K 01 Jan 2016 31 Mar 2016 10-Q 09 May 2016

Sigyn Therapeutics, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$821K +$870K +51.4% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 -$1.69M -$908K -116% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 -$783K +$214K +21.5% 01 Jan 2022 31 Dec 2022 10-K 20 Feb 2024
2021 -$996K -$653K -190% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$343K +$2.45M +87.7% 01 Jan 2020 31 Dec 2020 10-K 21 Mar 2022
2019 -$2.8M -$1.5M -115% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2020
2018 -$1.3M +$516K +28.4% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020
2017 -$1.82M 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019
2015 $441K 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.